Arthritis Therapeutic Market is expected to reach US$ 40.58 Bn. at a CAGR of 4.6% during the forecast period 2029. Arthritis is an inflammatory disorder affecting the joints cause redness, stiffness, resulting in pain and swelling in the joints. More than 100 categories of arthritis are affecting the global population. The most common arthritis conditions are psoriatic arthritis, rheumatoid arthritis, and osteoarthritis. The osteoarthritis affects a majority of the geriatric population, in severe joint pain and affecting their movement. Psoriatic Arthritis therapeutics contains drugs that help to reduce pain and inflammation.To know about the Research Methodology :- Request Free Sample Report The report study has analyzed revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers and market disrupters in the report and same is reflected in our analysis. Arthritis Therapeutic Market Drivers and Restrains The significant growth of the global arthritis therapeutics market is credited to investments in research & development, strong product pipeline, increasing patient pool suffering from arthritis. Furthermore, rise in the geriatric population is another factor fueling the growth of the global arthritis therapeutics market. Patients gone under treatment with Disease-Modifying Antirheumatic Drugs (DMARDs) are unsatisfied because of poor therapeutic benefits. The dominance of rheumatoid arthritis globally, the launch of novel therapeutic agents, and favorable reimbursement policies for high-cost treatment products are the factors that boost the growth of global arthritis therapeutics market. In 2022, the International Federation of Psoriasis Association (IFPA) states that more than 125 Mn people were affected with psoriasis. It is estimated that between 11% and 32% of patients with psoriasis incline to develop psoriatic arthritis. Furthermore, nearly 52.2 million adults suffered from arthritis in U.S. alone in 2015. Developments in diagnostics and healthcare infrastructure in developing countries are projected to witness an increased number of diagnosed patients. Manufacturers in the Arthritis Therapeutic are focusing on competitive pricing as the strategy to capture significant market share. Moreover, strategic mergers and acquisitions and technological innovations are also the key focus areas of the manufacturers.
Arthritis Therapeutic Market Segmentation Analysis
By Arthritis Therapeutic Market is segmented into Psoriatic Arthritis, Rheumatoid Arthritis, Osteoarthritis, Gout and Others. Rheumatoid Arthritis and Psoriatic Arthritis segment is expected to exhibit highest global market share at a CAGR of xx% over forecast period. Increasing occurrence of arthritis diseases globally, is likely to drive key players to develop novel therapeutics treatment for the disease. Strong research and development by key companies supported by huge investments is projected to drive the global arthritis therapeutics market. In 2022, according to the WHO statistics 9.9 % of men AND 18.1 % of women over the age of 60 suffered from osteoarthritis, symptomatic, worldwide. About 80 % of those with osteoarthritis have limitations in movement, and 25 % of women over the age of 60 suffered from symptomatic osteoarthritis, globally.Arthritis Therapeutic Market Regional Insights
The Global Arthritis Therapeutic Market has been classified into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East Africa. North America dominated the global arthritis therapeutics market, followed by Europe. Because of a large patient pool suffering from arthritis diseases, like osteoarthritis, rheumatoid arthritis and other conditions. Advantageous reimbursement policies, launching of novel biologics drugs, well-defined regulatory framework, and availability of biosimilars are boost up the market growth in the region. Furthermore, the presence of key players in the region and a strong product pipeline for arthritis treatment are projected to drive the arthritis therapeutics market in the region. This can be ascribed to awareness about arthritis, presence of key players, growing patient pool, favorable reimbursement policies, and availability of biosimilar and biologics arthritis drugs in the region. The objective of the report is to present comprehensive analysis of Global Arthritis Therapeutic Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers. The report also helps in understanding Global Arthritis Therapeutic Market dynamics, structure by analyzing the market segments, and project the Global Arthritis Therapeutic Market size. Clear representation of competitive analysis of key players by Arthritis Therapeutic Type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Arthritis Therapeutic Market make the report investor’s guide.Arthritis Therapeutic Market Scope: Inquire before buying
Global Arthritis Therapeutic Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 29.62 Bn. Forecast Period 2023 to 2029 CAGR: 4.6% Market Size in 2029: US $ 40.58 Bn. Segments Covered: by Type Psoriatic Arthritis Rheumatoid Arthritis Osteoarthritis Gout Others by Drug Class TNF Inhibitors Interleukin Inhibitors NSAIDs Corticosteroids Xanthine Oxidase Inhibitors Others by Route of Administration Oral Parenteral Topical by Distribution Channel Hospital Pharmacies Retail Pharmacies Online Pharmacies Arthritis Therapeutic Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria, Turkey, Russia and Rest of Europe) Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina, Columbia and Rest of South America)Arthritis Therapeutic Market, Key Players are
1. Pfizer Inc. 2. Bristol Myers Squibb 3. Abbvie Inc. 4. Astrazeneca Pharma 5. Ucb Pharma 6. Genentech 7. Janssen Pharmaceutical 8. Immunex Corp. 9. Medac Pharma 10. Boehringer Ingelheim 11. Novartis, Biogen 12. Eli Lilly And Company 13. Astellas Pharma 14. Mallinckrodt 15. Roche 16. Vertex Pharmaceutical 17. Amgen, Inc. 18. Merck & Co., Inc. 19. F. Hoffmann-La Roche Ltd 20. Sanofi 21. Celgene Corporation 22. Gilead Sciences, Inc. Frequently Asked Questions: 1. Which region has the largest share in Global Arthritis Therapeutic Market? Ans: North America region holds the highest share in 2022. 2. What is the growth rate of Global Arthritis Therapeutic Market? Ans: The Global Arthritis Therapeutic Market is growing at a CAGR of 4.6% during forecasting period 2023-2029. 3. What is scope of the Global Arthritis Therapeutic market report? Ans: Global Arthritis Therapeutic Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Arthritis Therapeutic market? Ans: The important key players in the Global Arthritis Therapeutic Market are – Pfizer Inc., Bristol Myers Squibb, Abbvie Inc., Astrazeneca Pharma, Ucb Pharma, Genentech, Janssen Pharmaceutical, Immunex Corp., Medac Pharma, Boehringer Ingelheim, Novartis, Biogen, Eli Lilly And Company, Astellas Pharma, Mallinckrodt, Roche, Vertex Pharmaceutical, Amgen, Inc., Merck & Co., Inc., F. Hoffmann-La Roche Ltd, Sanofi, Celgene Corporation, Gilead Sciences, and Inc. 5. What is the study period of this market? Ans: The Global Arthritis Therapeutic Market is studied from 2022 to 2029.
1. Arthritis Therapeutic Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Arthritis Therapeutic Market: Dynamics 2.1. Arthritis Therapeutic Market Trends by Region 2.1.1. North America Arthritis Therapeutic Market Trends 2.1.2. Europe Arthritis Therapeutic Market Trends 2.1.3. Asia Pacific Arthritis Therapeutic Market Trends 2.1.4. Middle East and Africa Arthritis Therapeutic Market Trends 2.1.5. South America Arthritis Therapeutic Market Trends 2.2. Arthritis Therapeutic Market Dynamics by Region 2.2.1. North America 2.2.1.1. North America Arthritis Therapeutic Market Drivers 2.2.1.2. North America Arthritis Therapeutic Market Restraints 2.2.1.3. North America Arthritis Therapeutic Market Opportunities 2.2.1.4. North America Arthritis Therapeutic Market Challenges 2.2.2. Europe 2.2.2.1. Europe Arthritis Therapeutic Market Drivers 2.2.2.2. Europe Arthritis Therapeutic Market Restraints 2.2.2.3. Europe Arthritis Therapeutic Market Opportunities 2.2.2.4. Europe Arthritis Therapeutic Market Challenges 2.2.3. Asia Pacific 2.2.3.1. Asia Pacific Arthritis Therapeutic Market Drivers 2.2.3.2. Asia Pacific Arthritis Therapeutic Market Restraints 2.2.3.3. Asia Pacific Arthritis Therapeutic Market Opportunities 2.2.3.4. Asia Pacific Arthritis Therapeutic Market Challenges 2.2.4. Middle East and Africa 2.2.4.1. Middle East and Africa Arthritis Therapeutic Market Drivers 2.2.4.2. Middle East and Africa Arthritis Therapeutic Market Restraints 2.2.4.3. Middle East and Africa Arthritis Therapeutic Market Opportunities 2.2.4.4. Middle East and Africa Arthritis Therapeutic Market Challenges 2.2.5. South America 2.2.5.1. South America Arthritis Therapeutic Market Drivers 2.2.5.2. South America Arthritis Therapeutic Market Restraints 2.2.5.3. South America Arthritis Therapeutic Market Opportunities 2.2.5.4. South America Arthritis Therapeutic Market Challenges 2.3. PORTER’s Five Forces Analysis 2.4. PESTLE Analysis 2.5. Technology Roadmap 2.6. Regulatory Landscape by Region 2.6.1. North America 2.6.2. Europe 2.6.3. Asia Pacific 2.6.4. Middle East and Africa 2.6.5. South America 2.7. Key Opinion Leader Analysis For Arthritis Therapeutic Industry 2.8. Analysis of Government Schemes and Initiatives For Arthritis Therapeutic Industry 2.9. Arthritis Therapeutic Market Trade Analysis 2.10. The Global Pandemic Impact on Arthritis Therapeutic Market 3. Arthritis Therapeutic Market: Global Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) 2022-2029 3.1. Arthritis Therapeutic Market Size and Forecast, by Type (2022-2029) 3.1.1. Psoriatic Arthritis 3.1.2. Rheumatoid Arthritis 3.1.3. Osteoarthritis 3.1.4. Gout 3.1.5. Others 3.2. Arthritis Therapeutic Market Size and Forecast, by Drug Class (2022-2029) 3.2.1. TNF Inhibitors 3.2.2. Interleukin Inhibitors 3.2.3. NSAIDs 3.2.4. Corticosteroids 3.2.5. Xanthine Oxidase Inhibitors 3.2.6. Others 3.3. Arthritis Therapeutic Market Size and Forecast, by Route of Administration (2022-2029) 3.3.1. Oral 3.3.2. Parenteral 3.3.3. Topical 3.4. Arthritis Therapeutic Market Size and Forecast, by Distribution Channel (2022-2029) 3.4.1. Hospital Pharmacies 3.4.2. Retail Pharmacies 3.4.3. Online Pharmacies 3.5. Arthritis Therapeutic Market Size and Forecast, by Region (2022-2029) 3.5.1. North America 3.5.2. Europe 3.5.3. Asia Pacific 3.5.4. Middle East and Africa 3.5.5. South America 4. North America Arthritis Therapeutic Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 4.1. North America Arthritis Therapeutic Market Size and Forecast, by Type (2022-2029) 4.1.1. Psoriatic Arthritis 4.1.2. Rheumatoid Arthritis 4.1.3. Osteoarthritis 4.1.4. Gout 4.1.5. Others 4.2. North America Arthritis Therapeutic Market Size and Forecast, by Drug Class (2022-2029) 4.2.1. TNF Inhibitors 4.2.2. Interleukin Inhibitors 4.2.3. NSAIDs 4.2.4. Corticosteroids 4.2.5. Xanthine Oxidase Inhibitors 4.2.6. Others 4.3. North America Arthritis Therapeutic Market Size and Forecast, by Route of Administration (2022-2029) 4.3.1. Oral 4.3.2. Parenteral 4.3.3. Topical 4.4. North America Arthritis Therapeutic Market Size and Forecast, by Distribution Channel (2022-2029) 4.4.1. Hospital Pharmacies 4.4.2. Retail Pharmacies 4.4.3. Online Pharmacies 4.5. North America Arthritis Therapeutic Market Size and Forecast, by Country (2022-2029) 4.5.1. United States 4.5.1.1. United States Arthritis Therapeutic Market Size and Forecast, by Type (2022-2029) 4.5.1.1.1. Psoriatic Arthritis 4.5.1.1.2. Rheumatoid Arthritis 4.5.1.1.3. Osteoarthritis 4.5.1.1.4. Gout 4.5.1.1.5. Others 4.5.1.2. United States Arthritis Therapeutic Market Size and Forecast, by Drug Class (2022-2029) 4.5.1.2.1. TNF Inhibitors 4.5.1.2.2. Interleukin Inhibitors 4.5.1.2.3. NSAIDs 4.5.1.2.4. Corticosteroids 4.5.1.2.5. Xanthine Oxidase Inhibitors 4.5.1.2.6. Others 4.5.1.3. United States Arthritis Therapeutic Market Size and Forecast, by Route of Administration (2022-2029) 4.5.1.3.1. Oral 4.5.1.3.2. Parenteral 4.5.1.3.3. Topical 4.5.1.4. United States Arthritis Therapeutic Market Size and Forecast, by Distribution Channel (2022-2029) 4.5.1.4.1. Hospital Pharmacies 4.5.1.4.2. Retail Pharmacies 4.5.1.4.3. Online Pharmacies 4.5.2. Canada 4.5.2.1. Canada Arthritis Therapeutic Market Size and Forecast, by Type (2022-2029) 4.5.2.1.1. Psoriatic Arthritis 4.5.2.1.2. Rheumatoid Arthritis 4.5.2.1.3. Osteoarthritis 4.5.2.1.4. Gout 4.5.2.1.5. Others 4.5.2.2. Canada Arthritis Therapeutic Market Size and Forecast, by Drug Class (2022-2029) 4.5.2.2.1. TNF Inhibitors 4.5.2.2.2. Interleukin Inhibitors 4.5.2.2.3. NSAIDs 4.5.2.2.4. Corticosteroids 4.5.2.2.5. Xanthine Oxidase Inhibitors 4.5.2.2.6. Others 4.5.2.3. Canada Arthritis Therapeutic Market Size and Forecast, by Route of Administration (2022-2029) 4.5.2.3.1. Oral 4.5.2.3.2. Parenteral 4.5.2.3.3. Topical 4.5.2.4. Canada Arthritis Therapeutic Market Size and Forecast, by Distribution Channel (2022-2029) 4.5.2.4.1. Hospital Pharmacies 4.5.2.4.2. Retail Pharmacies 4.5.2.4.3. Online Pharmacies 4.5.3. Mexico 4.5.3.1. Mexico Arthritis Therapeutic Market Size and Forecast, by Type (2022-2029) 4.5.3.1.1. Psoriatic Arthritis 4.5.3.1.2. Rheumatoid Arthritis 4.5.3.1.3. Osteoarthritis 4.5.3.1.4. Gout 4.5.3.1.5. Others 4.5.3.2. Mexico Arthritis Therapeutic Market Size and Forecast, by Drug Class (2022-2029) 4.5.3.2.1. TNF Inhibitors 4.5.3.2.2. Interleukin Inhibitors 4.5.3.2.3. NSAIDs 4.5.3.2.4. Corticosteroids 4.5.3.2.5. Xanthine Oxidase Inhibitors 4.5.3.2.6. Others 4.5.3.3. Mexico Arthritis Therapeutic Market Size and Forecast, by Route of Administration (2022-2029) 4.5.3.3.1. Oral 4.5.3.3.2. Parenteral 4.5.3.3.3. Topical 4.5.3.4. Mexico Arthritis Therapeutic Market Size and Forecast, by Distribution Channel (2022-2029) 4.5.3.4.1. Hospital Pharmacies 4.5.3.4.2. Retail Pharmacies 4.5.3.4.3. Online Pharmacies 5. Europe Arthritis Therapeutic Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 5.1. Europe Arthritis Therapeutic Market Size and Forecast, by Type (2022-2029) 5.2. Europe Arthritis Therapeutic Market Size and Forecast, by Drug Class (2022-2029) 5.3. Europe Arthritis Therapeutic Market Size and Forecast, by Route of Administration (2022-2029) 5.4. Europe Arthritis Therapeutic Market Size and Forecast, by Distribution Channel (2022-2029) 5.5. Europe Arthritis Therapeutic Market Size and Forecast, by Country (2022-2029) 5.5.1. United Kingdom 5.5.1.1. United Kingdom Arthritis Therapeutic Market Size and Forecast, by Type (2022-2029) 5.5.1.2. United Kingdom Arthritis Therapeutic Market Size and Forecast, by Drug Class (2022-2029) 5.5.1.3. United Kingdom Arthritis Therapeutic Market Size and Forecast, by Route of Administration (2022-2029) 5.5.1.4. United Kingdom Arthritis Therapeutic Market Size and Forecast, by Distribution Channel (2022-2029) 5.5.2. France 5.5.2.1. France Arthritis Therapeutic Market Size and Forecast, by Type (2022-2029) 5.5.2.2. France Arthritis Therapeutic Market Size and Forecast, by Drug Class (2022-2029) 5.5.2.3. France Arthritis Therapeutic Market Size and Forecast, by Route of Administration (2022-2029) 5.5.2.4. France Arthritis Therapeutic Market Size and Forecast, by Distribution Channel (2022-2029) 5.5.3. Germany 5.5.3.1. Germany Arthritis Therapeutic Market Size and Forecast, by Type (2022-2029) 5.5.3.2. Germany Arthritis Therapeutic Market Size and Forecast, by Drug Class (2022-2029) 5.5.3.3. Germany Arthritis Therapeutic Market Size and Forecast, by Route of Administration (2022-2029) 5.5.3.4. Germany Arthritis Therapeutic Market Size and Forecast, by Distribution Channel (2022-2029) 5.5.4. Italy 5.5.4.1. Italy Arthritis Therapeutic Market Size and Forecast, by Type (2022-2029) 5.5.4.2. Italy Arthritis Therapeutic Market Size and Forecast, by Drug Class (2022-2029) 5.5.4.3. Italy Arthritis Therapeutic Market Size and Forecast, by Route of Administration (2022-2029) 5.5.4.4. Italy Arthritis Therapeutic Market Size and Forecast, by Distribution Channel (2022-2029) 5.5.5. Spain 5.5.5.1. Spain Arthritis Therapeutic Market Size and Forecast, by Type (2022-2029) 5.5.5.2. Spain Arthritis Therapeutic Market Size and Forecast, by Drug Class (2022-2029) 5.5.5.3. Spain Arthritis Therapeutic Market Size and Forecast, by Route of Administration (2022-2029) 5.5.5.4. Spain Arthritis Therapeutic Market Size and Forecast, by Distribution Channel (2022-2029) 5.5.6. Sweden 5.5.6.1. Sweden Arthritis Therapeutic Market Size and Forecast, by Type (2022-2029) 5.5.6.2. Sweden Arthritis Therapeutic Market Size and Forecast, by Drug Class (2022-2029) 5.5.6.3. Sweden Arthritis Therapeutic Market Size and Forecast, by Route of Administration (2022-2029) 5.5.6.4. Sweden Arthritis Therapeutic Market Size and Forecast, by Distribution Channel (2022-2029) 5.5.7. Austria 5.5.7.1. Austria Arthritis Therapeutic Market Size and Forecast, by Type (2022-2029) 5.5.7.2. Austria Arthritis Therapeutic Market Size and Forecast, by Drug Class (2022-2029) 5.5.7.3. Austria Arthritis Therapeutic Market Size and Forecast, by Route of Administration (2022-2029) 5.5.7.4. Austria Arthritis Therapeutic Market Size and Forecast, by Distribution Channel (2022-2029) 5.5.8. Rest of Europe 5.5.8.1. Rest of Europe Arthritis Therapeutic Market Size and Forecast, by Type (2022-2029) 5.5.8.2. Rest of Europe Arthritis Therapeutic Market Size and Forecast, by Drug Class (2022-2029) 5.5.8.3. Rest of Europe Arthritis Therapeutic Market Size and Forecast, by Route of Administration (2022-2029) 5.5.8.4. Rest of Europe Arthritis Therapeutic Market Size and Forecast, by Distribution Channel (2022-2029) 6. Asia Pacific Arthritis Therapeutic Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 6.1. Asia Pacific Arthritis Therapeutic Market Size and Forecast, by Type (2022-2029) 6.2. Asia Pacific Arthritis Therapeutic Market Size and Forecast, by Drug Class (2022-2029) 6.3. Asia Pacific Arthritis Therapeutic Market Size and Forecast, by Route of Administration (2022-2029) 6.4. Asia Pacific Arthritis Therapeutic Market Size and Forecast, by Distribution Channel (2022-2029) 6.5. Asia Pacific Arthritis Therapeutic Market Size and Forecast, by Country (2022-2029) 6.5.1. China 6.5.1.1. China Arthritis Therapeutic Market Size and Forecast, by Type (2022-2029) 6.5.1.2. China Arthritis Therapeutic Market Size and Forecast, by Drug Class (2022-2029) 6.5.1.3. China Arthritis Therapeutic Market Size and Forecast, by Route of Administration (2022-2029) 6.5.1.4. China Arthritis Therapeutic Market Size and Forecast, by Distribution Channel (2022-2029) 6.5.2. S Korea 6.5.2.1. S Korea Arthritis Therapeutic Market Size and Forecast, by Type (2022-2029) 6.5.2.2. S Korea Arthritis Therapeutic Market Size and Forecast, by Drug Class (2022-2029) 6.5.2.3. S Korea Arthritis Therapeutic Market Size and Forecast, by Route of Administration (2022-2029) 6.5.2.4. S Korea Arthritis Therapeutic Market Size and Forecast, by Distribution Channel (2022-2029) 6.5.3. Japan 6.5.3.1. Japan Arthritis Therapeutic Market Size and Forecast, by Type (2022-2029) 6.5.3.2. Japan Arthritis Therapeutic Market Size and Forecast, by Drug Class (2022-2029) 6.5.3.3. Japan Arthritis Therapeutic Market Size and Forecast, by Route of Administration (2022-2029) 6.5.3.4. Japan Arthritis Therapeutic Market Size and Forecast, by Distribution Channel (2022-2029) 6.5.4. India 6.5.4.1. India Arthritis Therapeutic Market Size and Forecast, by Type (2022-2029) 6.5.4.2. India Arthritis Therapeutic Market Size and Forecast, by Drug Class (2022-2029) 6.5.4.3. India Arthritis Therapeutic Market Size and Forecast, by Route of Administration (2022-2029) 6.5.4.4. India Arthritis Therapeutic Market Size and Forecast, by Distribution Channel (2022-2029) 6.5.5. Australia 6.5.5.1. Australia Arthritis Therapeutic Market Size and Forecast, by Type (2022-2029) 6.5.5.2. Australia Arthritis Therapeutic Market Size and Forecast, by Drug Class (2022-2029) 6.5.5.3. Australia Arthritis Therapeutic Market Size and Forecast, by Route of Administration (2022-2029) 6.5.5.4. Australia Arthritis Therapeutic Market Size and Forecast, by Distribution Channel (2022-2029) 6.5.6. Indonesia 6.5.6.1. Indonesia Arthritis Therapeutic Market Size and Forecast, by Type (2022-2029) 6.5.6.2. Indonesia Arthritis Therapeutic Market Size and Forecast, by Drug Class (2022-2029) 6.5.6.3. Indonesia Arthritis Therapeutic Market Size and Forecast, by Route of Administration (2022-2029) 6.5.6.4. Indonesia Arthritis Therapeutic Market Size and Forecast, by Distribution Channel (2022-2029) 6.5.7. Malaysia 6.5.7.1. Malaysia Arthritis Therapeutic Market Size and Forecast, by Type (2022-2029) 6.5.7.2. Malaysia Arthritis Therapeutic Market Size and Forecast, by Drug Class (2022-2029) 6.5.7.3. Malaysia Arthritis Therapeutic Market Size and Forecast, by Route of Administration (2022-2029) 6.5.7.4. Malaysia Arthritis Therapeutic Market Size and Forecast, by Distribution Channel (2022-2029) 6.5.8. Vietnam 6.5.8.1. Vietnam Arthritis Therapeutic Market Size and Forecast, by Type (2022-2029) 6.5.8.2. Vietnam Arthritis Therapeutic Market Size and Forecast, by Drug Class (2022-2029) 6.5.8.3. Vietnam Arthritis Therapeutic Market Size and Forecast, by Route of Administration (2022-2029) 6.5.8.4. Vietnam Arthritis Therapeutic Market Size and Forecast, by Distribution Channel (2022-2029) 6.5.9. Taiwan 6.5.9.1. Taiwan Arthritis Therapeutic Market Size and Forecast, by Type (2022-2029) 6.5.9.2. Taiwan Arthritis Therapeutic Market Size and Forecast, by Drug Class (2022-2029) 6.5.9.3. Taiwan Arthritis Therapeutic Market Size and Forecast, by Route of Administration (2022-2029) 6.5.9.4. Taiwan Arthritis Therapeutic Market Size and Forecast, by Distribution Channel (2022-2029) 6.5.10. Rest of Asia Pacific 6.5.10.1. Rest of Asia Pacific Arthritis Therapeutic Market Size and Forecast, by Type (2022-2029) 6.5.10.2. Rest of Asia Pacific Arthritis Therapeutic Market Size and Forecast, by Drug Class (2022-2029) 6.5.10.3. Rest of Asia Pacific Arthritis Therapeutic Market Size and Forecast, by Route of Administration (2022-2029) 6.5.10.4. Rest of Asia Pacific Arthritis Therapeutic Market Size and Forecast, by Distribution Channel (2022-2029) 7. Middle East and Africa Arthritis Therapeutic Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 7.1. Middle East and Africa Arthritis Therapeutic Market Size and Forecast, by Type (2022-2029) 7.2. Middle East and Africa Arthritis Therapeutic Market Size and Forecast, by Drug Class (2022-2029) 7.3. Middle East and Africa Arthritis Therapeutic Market Size and Forecast, by Route of Administration (2022-2029) 7.4. Middle East and Africa Arthritis Therapeutic Market Size and Forecast, by Distribution Channel (2022-2029) 7.5. Middle East and Africa Arthritis Therapeutic Market Size and Forecast, by Country (2022-2029) 7.5.1. South Africa 7.5.1.1. South Africa Arthritis Therapeutic Market Size and Forecast, by Type (2022-2029) 7.5.1.2. South Africa Arthritis Therapeutic Market Size and Forecast, by Drug Class (2022-2029) 7.5.1.3. South Africa Arthritis Therapeutic Market Size and Forecast, by Route of Administration (2022-2029) 7.5.1.4. South Africa Arthritis Therapeutic Market Size and Forecast, by Distribution Channel (2022-2029) 7.5.2. GCC 7.5.2.1. GCC Arthritis Therapeutic Market Size and Forecast, by Type (2022-2029) 7.5.2.2. GCC Arthritis Therapeutic Market Size and Forecast, by Drug Class (2022-2029) 7.5.2.3. GCC Arthritis Therapeutic Market Size and Forecast, by Route of Administration (2022-2029) 7.5.2.4. GCC Arthritis Therapeutic Market Size and Forecast, by Distribution Channel (2022-2029) 7.5.3. Nigeria 7.5.3.1. Nigeria Arthritis Therapeutic Market Size and Forecast, by Type (2022-2029) 7.5.3.2. Nigeria Arthritis Therapeutic Market Size and Forecast, by Drug Class (2022-2029) 7.5.3.3. Nigeria Arthritis Therapeutic Market Size and Forecast, by Route of Administration (2022-2029) 7.5.3.4. Nigeria Arthritis Therapeutic Market Size and Forecast, by Distribution Channel (2022-2029) 7.5.4. Rest of ME&A 7.5.4.1. Rest of ME&A Arthritis Therapeutic Market Size and Forecast, by Type (2022-2029) 7.5.4.2. Rest of ME&A Arthritis Therapeutic Market Size and Forecast, by Drug Class (2022-2029) 7.5.4.3. Rest of ME&A Arthritis Therapeutic Market Size and Forecast, by Route of Administration (2022-2029) 7.5.4.4. Rest of ME&A Arthritis Therapeutic Market Size and Forecast, by Distribution Channel (2022-2029) 8. South America Arthritis Therapeutic Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 8.1. South America Arthritis Therapeutic Market Size and Forecast, by Type (2022-2029) 8.2. South America Arthritis Therapeutic Market Size and Forecast, by Drug Class (2022-2029) 8.3. South America Arthritis Therapeutic Market Size and Forecast, by Route of Administration(2022-2029) 8.4. South America Arthritis Therapeutic Market Size and Forecast, by Distribution Channel (2022-2029) 8.5. South America Arthritis Therapeutic Market Size and Forecast, by Country (2022-2029) 8.5.1. Brazil 8.5.1.1. Brazil Arthritis Therapeutic Market Size and Forecast, by Type (2022-2029) 8.5.1.2. Brazil Arthritis Therapeutic Market Size and Forecast, by Drug Class (2022-2029) 8.5.1.3. Brazil Arthritis Therapeutic Market Size and Forecast, by Route of Administration (2022-2029) 8.5.1.4. Brazil Arthritis Therapeutic Market Size and Forecast, by Distribution Channel (2022-2029) 8.5.2. Argentina 8.5.2.1. Argentina Arthritis Therapeutic Market Size and Forecast, by Type (2022-2029) 8.5.2.2. Argentina Arthritis Therapeutic Market Size and Forecast, by Drug Class (2022-2029) 8.5.2.3. Argentina Arthritis Therapeutic Market Size and Forecast, by Route of Administration (2022-2029) 8.5.2.4. Argentina Arthritis Therapeutic Market Size and Forecast, by Distribution Channel (2022-2029) 8.5.3. Rest Of South America 8.5.3.1. Rest Of South America Arthritis Therapeutic Market Size and Forecast, by Type (2022-2029) 8.5.3.2. Rest Of South America Arthritis Therapeutic Market Size and Forecast, by Drug Class (2022-2029) 8.5.3.3. Rest Of South America Arthritis Therapeutic Market Size and Forecast, by Route of Administration (2022-2029) 8.5.3.4. Rest Of South America Arthritis Therapeutic Market Size and Forecast, by Distribution Channel (2022-2029) 9. Global Arthritis Therapeutic Market: Competitive Landscape 9.1. MMR Competition Matrix 9.2. Competitive Landscape 9.3. Key Players Benchmarking 9.3.1. Company Name 9.3.2. Business Segment 9.3.3. End-user Segment 9.3.4. Revenue (2022) 9.3.5. Company Locations 9.4. Leading Arthritis Therapeutic Market Companies, by market capitalization 9.5. Market Structure 9.5.1. Market Leaders 9.5.2. Market Followers 9.5.3. Emerging Players 9.6. Mergers and Acquisitions Details 10. Company Profile: Key Players 10.1. Pfizer Inc. 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Scale of Operation (small, medium, and large) 10.1.7. Details on Partnership 10.1.8. Regulatory Accreditations and Certifications Received by Them 10.1.9. Awards Received by the Firm 10.1.10. Recent Developments 10.2. Bristol Myers Squibb 10.3. Abbvie Inc. 10.4. Astrazeneca Pharma 10.5. Ucb Pharma 10.6. Genentech 10.7. Janssen Pharmaceutical 10.8. Immunex Corp. 10.9. Medac Pharma 10.10. Boehringer Ingelheim 10.11. Novartis, Biogen 10.12. Eli Lilly And Company 10.13. Astellas Pharma 10.14. Mallinckrodt 10.15. Roche 10.16. Vertex Pharmaceutical 10.17. Amgen, Inc. 10.18. Merck & Co., Inc. 10.19. F. Hoffmann-La Roche Ltd 10.20. Sanofi 10.21. Celgene Corporation 10.22. Gilead Sciences, Inc. 11. Key Findings 12. Industry Recommendations 13. Arthritis Therapeutic Market: Research Methodology 14. Terms and Glossary